The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific

被引:84
|
作者
Niyuhire, Floride [1 ]
Varvel, Stephen A. [1 ]
Thorpe, Andrew J. [1 ]
Stokes, Rene J. [1 ]
Wiley, Jenny L. [1 ]
Lichtman, Aron H. [1 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
freezing; working memory; passive avoidance; fear conditioning; extinction; cannabinoid; operant conditioning task; marijuana; SR141716 (rimonabant); endocannabinoid;
D O I
10.1007/s00213-006-0650-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale Disruption of CB1 receptor signaling through the use of CB1 (-/-) mice or the CB1 receptor antagonist rimonabant (SR141716) has been demonstrated to impair extinction of learned responses in conditioned fear and Morris water maze tasks. In contrast, CB1 (-/-) mice exhibited normal extinction rates in an appetitively motivated operant conditioning task. Objectives The purpose of this study was to test whether rimonabant would differentially disrupt extinction learning between fear-motivated and food-motivated tasks. Materials and methods Separate groups of C57BL/6J mice were trained in two aversively motivated tasks, conditioned freezing and passive avoidance, and an appetitively motivated operant conditioning task at a fixed ratio (FR-5) schedule of food reinforcement. After acquisition, the respective reinforcers in each task were withheld, and an intraperitoneal injection of vehicle or rimonabant was given 30 min before each extinction session. Results Rimonabant (3 mg/kg) treatment significantly disrupted extinction in both the conditioned freezing and passive avoidance tasks but failed to affect extinction rates in the operant conditioning task, whether using daily or weekly extinction sessions. Interestingly, rimonabant (3 mg/kg) prevented the significant increases in lever pressing (i.e., extinction burst) that occurred during the first extinction session of the operant conditioning task. Conclusions These results support the hypothesis that the CB1 receptor plays a vital role in the extinction of aversive memories but is not essential for extinction of learned responses in appetitively motivated tasks.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 50 条
  • [1] The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific
    Floride Niyuhire
    Stephen A. Varvel
    Andrew J. Thorpe
    Rene J. Stokes
    Jenny L. Wiley
    Aron H. Lichtman
    Psychopharmacology, 2007, 191 : 223 - 231
  • [2] Context-specific reversal of cocaine Sensitization by the CB1 cannabinoid receptor antagonist rimonabant
    Gerdeman, Gregory L.
    Schechter, Jason B.
    French, Edward D.
    NEUROPSYCHOPHARMACOLOGY, 2008, 33 (11) : 2747 - 2759
  • [3] Context-Specific Reversal of Cocaine Sensitization by the CB1 Cannabinoid Receptor Antagonist Rimonabant
    Gregory L Gerdeman
    Jason B Schechter
    Edward D French
    Neuropsychopharmacology, 2008, 33 : 2747 - 2759
  • [4] Rimonabant - A selective CB1 antagonist
    Boyd, ST
    Fremming, BA
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (04) : 684 - 690
  • [5] Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats
    Pattij, Tommy
    Janssen, Mieke C. W.
    Schepers, Inga
    Gonzalez-Cuevas, Gustavo
    de Vries, Taco J.
    Schoffelmeer, Anton N. M.
    PSYCHOPHARMACOLOGY, 2007, 193 (01) : 85 - 96
  • [6] Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats
    Tommy Pattij
    Mieke C. W. Janssen
    Inga Schepers
    Gustavo González-Cuevas
    Taco J. de Vries
    Anton N. M. Schoffelmeer
    Psychopharmacology, 2007, 193 : 85 - 96
  • [7] Disruption of CB1 receptor signaling impairs extinction of spatial memory in mice
    S. A. Varvel
    E. A. Anum
    A. H. Lichtman
    Psychopharmacology, 2005, 179 : 863 - 872
  • [8] Disruption of CB1 receptor signaling impairs extinction of spatial memory in mice
    Varvel, SA
    Anum, EA
    Lichtman, AH
    PSYCHOPHARMACOLOGY, 2005, 179 (04) : 863 - 872
  • [9] Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease
    González, S
    Scorticati, C
    García-Arencibia, M
    de Miguel, R
    Ramos, JA
    Fernández-Ruiz, J
    BRAIN RESEARCH, 2006, 1073 : 209 - 219
  • [10] The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction
    Shiang Y. Lim
    Sean M. Davidson
    Derek M. Yellon
    Christopher C. T. Smith
    Basic Research in Cardiology, 2009, 104 : 781 - 792